Chung Owyang, MD, a former gastroenterology researcher at Ann Arbor-based Michigan Medicine, was fired for alleged falsified or fabricated data in multiple publications, MLive reported Jan. 24.
The FDA has approved the use of tucatinib — a drug engineered by biotech company Seagen — in tandem with trastuzumab as a second-line treatment for colorectal cancer that has not responded to other therapies.
Rhode Island’s largest gastroenterology group, University Gastroenterology, has named Eric Newton, MD, as its next president, according to a Jan. 19 press release sent to Becker’s.
Oshi Health, a virtual digestive healthcare company, has named Maria Abreu, MD, future president of the American Gastroenterological Association, to its medical advisory board.